December 31, 2013 | As cancer grows more and more common in low-income companies, this chronic illness once thought of as a "rich nation's disease" is drawing parallels to the AIDS crisis of the 90's – at least where pharmaceutical patents are concerned. In India, where hundreds of thousands are killed by cancer every year, patents held by international drug giants that keep the price of therapies beyond reach for most Indians are coming under fire in the courts and embassies. New York Times